135 / 400
MONDAY
TUESDAY
WEDNESDAY
THURSDAY
German language Session
Q&A Modul
SCIENTIFIC PROGRAMME
127
S-126
Symposium
08:15–09:45
|
Hall Paris 2
TOPIC 38:
Human Rights
The psychiatrist and transgender care: diagnosis,
hormones, surgery and special considerations
Chairs:
Christopher McIntosh, Canada
Gene Nakajima, USA
001
Should diagnosis of gender dysphoria be a
prerequisite for medical treatment?
Annette Güldenring, Germany
002
An approach to the adolescent with gender
dysphoria
Richard Montoro, Canada
003
Hormone therapy and gender dysphoria
Eric Yarbrough, USA
004
Mental health assessment for transgender
people seeking surgery
Christopher McIntosh, Canada
S-127
Symposium
08:15–09:45
|
Hall Berlin 1
TOPIC 38:
Human Rights
The German Association for Psychiatry, Psychother-
apy and Psychosomatics (DGPPN) and its action
plan to implement the United Nations Convention
on the Rights of Persons with Disabilities (CRPD) in
German psychiatry
Chairs:
Michael Seidel, Germany
Arno Deister, Germany
001
The United Nations Convention on the Rights
of Persons with Disabilities – a challenge for the
DGPPN
Arno Deister, Germany
002
The action plan of the DGPPN
Michael Seidel, Germany
003
Impact and relevance of the CRPD on psychiatric
services
Katarina Stengler, Germany
S-128
Symposium
08:15–09:45
|
Hall New York 1
TOPIC 12:
Epidemiology and risk factors
New horizons in psychiatric epidemiology using
electronic health records
Chairs:
Richard Hayes, United Kingdom
Gayan Perera, United Kingdom
001
Using linkages between education and electron-
ic mental health record data to examine predictors
of attention-deficit hyperactivity disorder (ADHD)
and ADHD medication use
Johnny Downs, United Kingdom
002
Mortality of people with chronic fatigue
syndrome and the risk of suicide deaths in relation
to comorbidity of depression
Chin-Kuo Chang, United Kingdom
003
Polypharmacy and specific medication profiles
as predictors of treatment and health outcomes in
dementia
Christoph Mueller, United Kingdom
004
Future directions in the use of electronic health
records to support novel research into mental
health interventions and outcomes
Robert Stewart, United Kingdom
S-129
Symposium
08:15–09:45
|
Hall New York 3
TOPIC 20:
Prevention and health promotion
Results of new intervention trials in people at
clinical high risk of psychosis
›
DGPPN Section: Prevention of Mental Disorders
Chairs:
Joachim Klosterkötter, Germany
Patrick McGorry, Australia
001
A randomized controlled trial of cognitive be-
havior therapy versus non-directive reflective listen-
ing for young people at risk of developing psychosis
Helen J. Stain, United Kingdom
002
The four-year follow-up data of cognitive
behavioral therapy for ultrahigh risk subjects
Mark van der Gaag, The Netherlands
Helga Ising
003
PREVENT: a randomized controlled trial
comparing cognitive behavioral therapy, clinical
management and aripiprazole and clinical manage-
ment and placebo for the prevention of first episode
psychosis
Andreas Bechdolf, Germany